Hair cortisol levels in schizophrenia and metabolic syndrome.
cardiovascular disease
first-episode psychosis
hydrocortisone
hypothalamic-pituitary-adrenal axis
stress
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
16
08
2021
received:
24
08
2020
accepted:
19
10
2021
pubmed:
4
1
2022
medline:
4
8
2022
entrez:
3
1
2022
Statut:
ppublish
Résumé
Individuals with schizophrenia demonstrate higher rates of metabolic syndrome (MetS) than the general population. Hair cortisol concentrations (HCC) reflect longer-term cortisol secretion and can provide additional insights into the role of the hypothalamic pituitary adrenal (HPA) axis in schizophrenia and co-occurring MetS. In a case-control study of 16 patients with schizophrenia (11 first episode psychosis [FEP] and 5 chronic) and 21 controls hair samples, representing a 3-month retrospective window of cortisol, were collected and analysed utilizing liquid chromatography tandem mass spectrometry. We investigated whether schizophrenia and MetS co-occurrence were associated with HCC utilizing multivariate regression models. We also explored the longitudinal trajectory of HCC in FEP patients by conducting a mixed models analysis. At baseline HCC were significantly lower (Cohen's d = 0.88) in patients with schizophrenia than in controls (p = .014). HCC increased from baseline to month-12 in FEP patients compared to controls, demonstrating a trend towards significance (p = .097). MetS was not associated with HCC at baseline, but HCC increased significantly from baseline to month-12 in relation to MetS (p = .037). In a subgroup of schizophrenia patients, psychosis may be associated with a blunted HPA axis with lower long-term cortisol output. MetS was associated with an increase in HCC and elevated cortisol levels observed in schizophrenia may be related to increased rates of MetS in schizophrenia patients.
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
902-911Informations de copyright
© 2022 John Wiley & Sons Australia, Ltd.
Références
Aas, M., Pizzagalli, D. A., Laskemoen, J. F., Reponen, E. J., Ueland, T., Melle, I., Agartz, I., Steen, N. E., & Andreassen, O. A. (2019). Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders. Schizophrenia Research, 213, 65-71. https://doi.org/10.1016/j.schres.2019.01.011
Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P., Loria, C. M., & Smith, S. C., Jr. (2009). Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Andrade, E. H., Rizzo, L. B., Noto, C., Ota, V. K., Gadelha, A., Daruy-Filho, L., Tasso, B. de C., Mansur, R. B., Cordeiro, Q., Belangero, S. I., Bressan, R. A., Grassi-Oliveira, R., & Brietzke, E. (2016). Hair cortisol in drug-naïve first-episode individuals with psychosis. Revista Brasileira de Psiquiatria, 38(1), 11-16. https://doi.org/10.1590/1516-4446-2014-1634
Anglin, R. E., Rosebush, P. I., & Mazurek, M. F. (2006). The neuropsychiatric profile of Addison's disease: Revisiting a forgotten phenomenon. Journal of Neuropsychiatry and Clinical Neurosciences, 18(4), 450-459. https://doi.org/10.1176/jnp.2006.18.4.450
Borges, S., Gayer-Anderson, C., & Mondelli, V. (2013). A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis. Psychoneuroendocrinology, 38(5), 603-611. https://doi.org/10.1016/j.psyneuen.2012.12.025
Bradley, A. J., & Dinan, T. G. (2010). A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: Implications for mortality. Journal of Psychopharmacology (Oxford, England), 24(4 suppl), 91-118. https://doi.org/10.1177/1359786810385491
Chaumette, B., Kebir, O., Mam-Lam-Fook, C., Morvan, Y., Bourgin, J., Godsil, B. P., Plaze, M., Gaillard, R., Jay, T. M., & Krebs, M. O. (2016). Salivary cortisol in early psychosis: New findings and meta-analysis. Psychoneuroendocrinology, 63, 262-270. https://doi.org/10.1016/j.psyneuen.2015.10.007
Chiliza, B., Ojagbemi, A., Esan, O., Asmal, L., Oosthuizen, P., Kidd, M., Gureje, O., & Emsley, R. (2016). Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting. Early Intervention in Psychiatry, 10(1), 54-62. https://doi.org/10.1111/eip.12141
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa-Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., Pigato, G., Favaro, A., Monaco, F., Kohler, C., Vancampfort, D., Ward, P. B., Gaughran, F., Carvalho, A. F., & Stubbs, B. (2017). Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry, 16(2), 163-180. https://doi.org/10.1002/wps.20420
De Hert, M., Detraux, J., & Vancampfort, D. (2018). The intriguing relationship between coronary heart disease and mental disorders. Dialogues in Clinical Neuroscience, 20(1), 31-40.
Farah, J. d. L., Lauand, C. V., Chequi, L., Fortunato, E., Pasqualino, F., Bignotto, L. H., Batista, R. L., & Aprahamian, I. (2015). Severe psychotic disorder as the main manifestation of adrenal insufficiency. Case Reports in Psychiatry, 2015, 1-4. https://doi.org/10.1155/2015/512430
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured clinical interview for DSM-IV Axis I disorders, clinical version (SCID-CV). American Psychiatric Press.
Fujii, Y., Mizoguchi, Y., Masuoka, J., Matsuda, Y., Abe, T., Anzai, K., Kunitake, Y., Tateishi, H., Inaba, T., Murakawa, T., Kato, T., & Monji, A. (2018). Cushing's syndrome and psychosis: A case report and literature review. The Primary Care Companion for CNS Disordersfor CNS Disorders, 20(5), 18br02279. https://doi.org/10.4088/pcc.18br02279
Gajsak, L. R., Gelemanovic, A., Kuzman, M. R., & Puljak, L. (2017). Impact of stress response in development of first-episode psychosis in schizophrenia: An overview of systematic reviews. Psychiatria Danubina, 29(1), 14-23.
Gao, W., Stalder, T., Foley, P., Rauh, M., Deng, H., & Kirschbaum, C. (2013). Quantitative analysis of steroid hormones in human hair using a column-switching LC-APCI-MS/MS assay. Journal of Chromatography B, 928, 1-8. https://doi.org/10.1016/j.jchromb.2013.03.008
Girshkin, L., Matheson, S. L., Shepherd, A. M., & Green, M. J. (2014). Morning cortisol levels in schizophrenia and bipolar disorder: A meta-analysis. Psychoneuroendocrinology, 49(1), 187-206. https://doi.org/10.1016/j.psyneuen.2014.07.013
Hubbard, D. B., & Miller, B. J. (2019). Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology, 104(September 2018), 269-275. https://doi.org/10.1016/j.psyneuen.2019.03.014
Kuehl, L. K., Hinkelmann, K., Muhtz, C., Dettenborn, L., Wingenfeld, K., Spitzer, C., Kirschbaum, C., Wiedemann, K., & Otte, C. (2015). Hair cortisol and cortisol awakening response are associated with criteria of the metabolic syndrome in opposite directions. Psychoneuroendocrinology, 51, 365-370. https://doi.org/10.1016/j.psyneuen.2014.09.012
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014). Excess early mortality in schizophrenia. Annual Review of Clinical Psychology, 10(1), 425-448. https://doi.org/10.1146/annurev-clinpsy-032813-153657
Manzanares, N., Monseny, R., Ortega, L., Montalvo, I., Franch, J., Gutiérrez-Zotes, A., Reynolds, R. M., Walker, B. R., Vilella, E., & Labad, J. (2014). Unhealthy lifestyle in early psychoses: The role of life stress and the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology, 39(1), 1-10. https://doi.org/10.1016/j.psyneuen.2013.09.023
Matsha, T. E., Hassan, M. S., Hon, G. M., Soita, D. J., Kengne, A. P., & Erasmus, R. T. (2013). Derivation and validation of a waist circumference optimal cutoff for diagnosing metabolic syndrome in a South African mixed ancestry population. International Journal of Cardiology, 168(3), 2954-2955. https://doi.org/10.1016/j.ijcard.2013.03.150
Mitchell, A. J., Vancampfort, D., Sweers, K., Van Winkel, R., Yu, W., & De Hert, M. (2013). Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophrenia Bulletin, 39(2), 306-318. https://doi.org/10.1093/schbul/sbr148
Mondelli, V., Ciufolini, S., Murri, M. B., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., Pariante, C. M., & Dazzan, P. (2015). Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophrenia Bulletin, 41(5), 1162-1170. https://doi.org/10.1093/schbul/sbv028
Penninx, B. W. J. H., & Lange, S. M. M. (2018). Metabolic syndrome in psychiatric patients: Overview, mechanisms, and implications. Dialogues in Clinical Neuroscience, 20(1), 63-73.
Piotrowski, P., Gondek, T. M., Królicka-Derȩgowska, A., Misiak, B., Adamowski, T., & Kiejna, A. (2017). Causes of mortality in schizophrenia: An updated review of European studies. Psychiatria Danubina, 29(2), 108-120. https://doi.org/10.24869/psyd.2017.108
Pulopulos, M. M., Hidalgo, V., Almela, M., Puig-Perez, S., Villada, C., & Salvador, A. (2014). Hair cortisol and cognitive performance in healthy older people. Psychoneuroendocrinology, 44, 100-111. https://doi.org/10.1016/j.psyneuen.2014.03.002
Russell, E., Kirschbaum, C., Laudenslager, M. L., Stalder, T., Rijke, Y. De, van Rossum, E. F. C., van Uum, S., & Koren, G. (2015). Toward standardization of hair cortisol measurement: Results of the first international Interlaboratory round Robin. Therapeutic Drug Monitoring, 37(1), 71-75. https://doi.org/10.1097/FTD.0000000000000148
Seitz, R., Vracotas, N., Bechard-Evans, L., King, S., Abadi, S., Joober, R., Shah, J. L., Malla, A. K., & Pruessner, M. (2019). The trier social stress test in first episode psychosis patients: Impact of perceived stress, protective factors and childhood trauma. Psychoneuroendocrinology, 105(July 2018), 155-163. https://doi.org/10.1016/j.psyneuen.2019.01.010
Sheehan, D. V, Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The MINI-international neuropsychiatric interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(suppl 20), 22-33 https://psycnet.apa.org/record/1998-03251-004
Stalder, T., & Kirschbaum, C. (2012). Analysis of cortisol in hair-state of the art and future directions. Brain, Behavior, and Immunity, 26(7), 1019-1029. https://doi.org/10.1016/j.bbi.2012.02.002
Stalder, T., Kirschbaum, C., Alexander, N., Bornstein, S. R., Gao, W., Miller, R., Stark, S., Bosch, J. A., & Fischer, J. E. (2013). Cortisol in hair and the metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism, 98(6), 2573-2580. https://doi.org/10.1210/jc.2013-1056
Stalder, T., Steudte-Schmiedgen, S., Alexander, N., Klucken, T., Vater, A., Wichmann, S., Kirschbaum, C., & Miller, R. (2017). Stress-related and basic determinants of hair cortisol in humans: A meta-analysis. Psychoneuroendocrinology, 77, 261-274. https://doi.org/10.1016/j.psyneuen.2016.12.017
Streit, F., Memic, A., Hasandedić, L., Rietschel, L., Frank, J., Lang, M., Witt, S. H., Forstner, A. J., Degenhardt, F., Wüst, S., Nöthen, M. M., Kirschbaum, C., Strohmaier, J., Oruc, L., & Rietschel, M. (2016). Perceived stress and hair cortisol: Differences in bipolar disorder and schizophrenia. Psychoneuroendocrinology, 69, 26-34. https://doi.org/10.1016/j.psyneuen.2016.03.010
Touskova, T. P., Bob, P., Pec, O., Mishara, A., Vanickova, Z., Raboch, J., & Lysaker, P. (2018). Insight and cortisol responses in women with first episode psychosis. Schizophrenia Research, 201, 428-429. https://doi.org/10.1016/j.schres.2018.06.002
van den Heuvel, L. L., Acker, D., du Plessis, S., Stalder, T., Suliman, S., Thorne, M. Y., Kirschbaum, C., & Seedat, S. (2020). Hair cortisol as a biomarker of stress and resilience in South African mixed ancestry females. Psychoneuroendocrinology, 113(March 2020), 104543. https://doi.org/10.1016/j.psyneuen.2019.104543
van den Heuvel, L. L., du Plessis, S., Stalder, T., Acker, D., Kirschbaum, C., Carr, J., & Seedat, S. (2020). Hair glucocorticoid levels in Parkinson's disease. Psychoneuroendocrinology, 117(January), 104704. https://doi.org/10.1016/j.psyneuen.2020.104704
van den Heuvel, L. L., Stalder, T., du Plessis, S., Suliman, S., Kirschbaum, C., & Seedat, S. (2020). Hair cortisol levels in posttraumatic stress disorder and metabolic syndrome. Stress, 1-13, 577-589. https://doi.org/10.1080/10253890.2020.1724949
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry, 14(3), 339-347. https://doi.org/10.1002/wps.20252
Vancampfort, D., Wampers, M., Mitchell, A. J., Correll, C. U., De Herdt, A., Probst, M., & De Hert, M. (2013). A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry, 12(3), 240-250. https://doi.org/10.1002/wps.20069
Vuksan-Cúsa, B., Sǎgud, M., Mihaljevic-́Peleš, A., Jaksǐć, N., & Jakovljev́ic, M. (2014). Metabolic syndrome and cortisol/dheas ratio in patients with bipolar disorder and schizophrenia. Psychiatria Danubina, 26(2), 187-189.
Wennig, R. (2000). Potential problems with the interpretation of hair analysis results. Forensic Science International, 107(1), 5-12. https://doi.org/10.1016/S0379-0738(99)00146-2
World Health Organization. (2005). WHO STEPS surveillance manual: The WHO STEPwise approach to chronic disease risk factor surveillance. World Health Organization (WHO).
Wosu, A. C., Valdimarsdóttir, U., Shields, A. E., Williams, D. R., & Williams, M. A. (2013). Correlates of cortisol in human hair: Implications for epidemiologic studies on health effects of chronic stress. Annals of Epidemiology, 23(12), 797-811. https://doi.org/10.1016/j.annepidem.2013.09.006